Alder Biopharmaceuticals Inc. To Present At Two Conferences In June

Published: Jun 11, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOTHELL, Wash., June 11, 2014 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc., ("Alder") (Nasdaq:ALDR), a clinical-stage biopharmaceutical company developing therapeutic antibodies for the treatment of migraine, autoimmune and inflammatory diseases, today announced that members of Alder's senior management team will present at two upcoming conferences in June:

Help employers find you! Check out all the jobs and post your resume.

Back to news